KN is on the advisory board of Novo Nordisk, Novartis, Esperion, Merck Sharp and Dohme, and ER Squib & Sons. Receives speaker honoraria from Amgen. KN's research is partly supported by grants from National Institutes of Health, Patient-Centered Outcomes Research Institute, Novartis, and Esperion. KN serves on the editorial board for the Journal of the American College of Cardiology and the board of directors for the American Society of Preventive Cardiology.